FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3090433181> ?p ?o ?g. }

• W3090433181 abstract "In January 2020, with the increase in COVID-19-infected cases affecting more than 170 countries, the WHO declared this outbreak a public health emergency of international concern; on March 11, it was declared a pandemic.1, 2 The first case in Spain was diagnosed in 1 February 2020 and in Catalonia in 25 February 20203, 4 Since then, different protocols were issued to prevent exposure to the new virus and to improve management strategies. The first national guidelines for the prevention of occupational hazard against the novel coronavirus were issued by the Ministry of Health on March 5, establishing a series of preventive measures which included reducing face-to-face visits and on-site staff, limiting exposure at workplaces such as hospitals.5 At Vall d´Hebron Hospital in Barcelona, the first protocol regarding COVID-19 was issued on March 11, the same day that schools and other educational centres were closed down in the city. On March 15, a national lockdown was established after declaring the state of emergency.6 The Haemophilia Unit (HU) at Vall d’ Hebron Hospital provides comprehensive and dedicated care to patients with bleeding disorders. It has a multidisciplinary team lead by haematologists, 2 on weekdays and 1 on call for nights and weekends. The nursing staff is divided in 3 shifts to guarantee 24/7 attention, having 2 nurses during weekday mornings to guarantee better coverage during the busiest shift. The HU also includes orthopaedic trauma surgeons, a physical rehabilitation specialist, a hepatologist, an infectious disease specialist and a dentist who visit the patients at the HU once or twice a week. The hospital's pharmacy department supplies the haemostatic treatment to the patients and guarantees a proper supply and traceability of the clotting factor concentrates. To do so, patients need to book an appointment with the hospital´s pharmacy, in order to pick up their monthly medication prescribed by the haematology team. With the COVID-19 outbreak, the Unit searched for a new system to continue providing the same medical attention without putting the patients or staff at risk. We analysed the organization and activity of the HU during the 73 days of the state of emergency period (March 9-May 20). The change in activity was measured with the available data from the in-person visits, tele-visits, blood extractions and treatments performed by the HU healthcare providers. We then compared them with the activity of the same period during the year before. The analysis was performed weekly and over the entire study period mentioned above. At the HU, we started to carry out preventive measures 6 days before the full lockdown. The in-person visits were restricted to emergencies related to bleeding disorders, encouraging telemedicine for the rest of the consults. The on-site staff was reduced to the minimum necessary, with only 1 haematologist on-site while the other was tele-working, and 1 nurse on 12 hours shifts. The 24/7 coverage was guaranteed with the original nursing team and the haematologist on-call. The haematology team reviewed on a daily basis the scheduled face-to-face visits between March 10 and May 20, identifying the visits which could be carried out remotely. Most of the routine follow-up visits were carried out over the phone in March or, if possible, postponed until June and onwards. Urgent outpatient visits were carried out, usually related to recent bleeding events, as well as postoperative follow-ups in these patients. Regarding clinical trials, screening and baseline visits were postponed until the end of the state of emergency. Follow-ups were done by phone if possible. In-person visits were performed only if the study protocol required it. The nurse consult was done remotely reviewing the e-diary Haemoassist® and contacting patients over the phone in order to maintain follow-up on prophylactic treatment and adherence control. The hospital visits were restricted to patients who needed hospital administration of haemostatic treatments and urgent blood extractions. Regarding the pharmacy department, during the first 2 weeks of March they confirmed stocks with all pharmaceutical companies who provide haemostatic medication to ensure the necessary supply for our patients, even if the borders closed. They also started the ‘Home Delivery Programme’ aiming to distribute the haemostatic medication to the patient´s home, avoiding the monthly pickup trips to the hospital. As a result of the new COVID-19 contingency plan at the HU, we observed a 38% increase in tele-visits performed by the haematology team in comparison with the previous year (371 vs 470). On the other hand, the analysis showed a 73% reduction in scheduled in-person visits (343 vs 92), concerning follow-up and first visits; and a 55% reduction in the number of emergencies attended at the HU (78 vs 35) in comparison with the previous year (Figure 1). Regarding the nursing activity, a reduction in the work volume was observed, as blood extractions were 53% less than the previous year (395 vs 184) and administered treatments dropped 25% (605 vs 453) compared with the 2019 period (Figure 1). The weekly analysis (Figure 2) showed that the highest volume of visits occurred during the first 2 weeks of the pandemic (31.2% of the entire medical activity of this 2020 period) because patients needed more information regarding the virus and the care required. After those first weeks, we observed a global reduction of activity (reduction of 81%-95%) that coincided with the Spanish home-confinement period, as well as the fact that our bleeding disorder population was already informed about the pandemic and the changes regarding the medical attention at the HU. The reduction in on-site visits was mainly due to the remote follow-up but it is also possible that the lockdown caused a reduction of physical activity and less bleeding events in our patients. During the weeks of May 2020, healthcare providers’ activity started to increase, coinciding with the end of the confinement period and the start of the de-escalation plan in Barcelona. This is possible due to subsequent restart of sports activities as well as the restart of some invasive procedures scheduled at our hospital. The Home Delivery Programme was able to deliver clotting factors all over Catalonia. At first, home supply to patients who lived outside the city of Barcelona or had special needs was prioritized but it was quickly extended to all patients. Two-hundred and thirty refrigerated shipments were delivered for monthly consumption to a total of 124 patients during the period of 9 March and 20 May 2020. Those shipments represented 95% of all haemostatic treatment supplied to patients. The other 5% was supplied at the HU to patients who came for on-site visits. The shipments involved a total of 460 phone calls (Over 400% more than the period before) between the hospital pharmacy team and nurse team with the patients, to ensure package delivery as well as for the treatment adherence recall. The clinical follow-up continued to be done with the Haemoassist® App in 80% of the patients. The pandemic has changed the management of patients with chronic diseases such as bleeding disorders, increasing the use of telemedicine tools to ease the healthcare system.7, 8 This includes a variety of technologies to ensure remote medical attention such as live audio and video calls, e-portals or other type of messaging technologies, remote patient-monitoring tools (For example the Haemoassist® App which we have been using in our unit for many years now) and store-and-forward technologies that collect images and data to be transmitted at a later time.8, 9 In our centre, before and during the pandemic, the telemedicine tools available were only phone calls and e-diaries. Now, video consults are available and face-to-face visits are still restricted to patients who need a physical examination or additional tests. The Home Delivery Programme has been especially important to distribute haemostatic treatment to patients all over Catalonia, avoiding hospital visits during the confinement period and the SARS-CoV-2 infection. This programme will continue, prioritizing patients who live outside the city of Barcelona. Martínez García, MF and Benitez Hidalgo, O designed the study, collected data and analysed results. Martínez García, MF wrote and edited the manuscript too. Alvarez Martinez, E; Juarez Gimenez, JC; Fernandez Sarmiento, C; Suito Alcantara, M; Soto Bonet, N and Cardona Lopez, R collected data. Iacoboni Garcia-Calvo, G helped editing the manuscript. Gironella Mesa, M supervised the study. The authors have no competing interests." @default.
• W3090433181 created "2020-10-08" @default.
• W3090433181 creator A5004999391 @default.
• W3090433181 creator A5018120272 @default.
• W3090433181 creator A5049920551 @default.
• W3090433181 creator A5057799818 @default.
• W3090433181 creator A5061722014 @default.
• W3090433181 creator A5062740663 @default.
• W3090433181 creator A5077436992 @default.
• W3090433181 creator A5080004353 @default.
• W3090433181 creator A5085243567 @default.
• W3090433181 creator A5090475382 @default.
• W3090433181 date "2020-09-30" @default.
• W3090433181 modified "2023-09-27" @default.
• W3090433181 title "Organization of a reference haemophilia unit and its change of activity during the COVID‐19 pandemic" @default.
• W3090433181 cites W2802912007 @default.
• W3090433181 cites W2994833293 @default.
• W3090433181 cites W3010223921 @default.
• W3090433181 doi "https://doi.org/10.1111/hae.14160" @default.
• W3090433181 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7537136" @default.
• W3090433181 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32997851" @default.
• W3090433181 hasPublicationYear "2020" @default.
• W3090433181 type Work @default.
• W3090433181 sameAs 3090433181 @default.
• W3090433181 citedByCount "3" @default.
• W3090433181 countsByYear W30904331812021 @default.
• W3090433181 countsByYear W30904331812022 @default.
• W3090433181 crossrefType "journal-article" @default.
• W3090433181 hasAuthorship W3090433181A5004999391 @default.
• W3090433181 hasAuthorship W3090433181A5018120272 @default.
• W3090433181 hasAuthorship W3090433181A5049920551 @default.
• W3090433181 hasAuthorship W3090433181A5057799818 @default.
• W3090433181 hasAuthorship W3090433181A5061722014 @default.
• W3090433181 hasAuthorship W3090433181A5062740663 @default.
• W3090433181 hasAuthorship W3090433181A5077436992 @default.
• W3090433181 hasAuthorship W3090433181A5080004353 @default.
• W3090433181 hasAuthorship W3090433181A5085243567 @default.
• W3090433181 hasAuthorship W3090433181A5090475382 @default.
• W3090433181 hasBestOaLocation W30904331811 @default.
• W3090433181 hasConcept C116675565 @default.
• W3090433181 hasConcept C122637931 @default.
• W3090433181 hasConcept C142724271 @default.
• W3090433181 hasConcept C145420912 @default.
• W3090433181 hasConcept C159047783 @default.
• W3090433181 hasConcept C187212893 @default.
• W3090433181 hasConcept C2778385053 @default.
• W3090433181 hasConcept C2779134260 @default.
• W3090433181 hasConcept C3006700255 @default.
• W3090433181 hasConcept C3007834351 @default.
• W3090433181 hasConcept C3008058167 @default.
• W3090433181 hasConcept C33923547 @default.
• W3090433181 hasConcept C524204448 @default.
• W3090433181 hasConcept C71924100 @default.
• W3090433181 hasConcept C89623803 @default.
• W3090433181 hasConceptScore W3090433181C116675565 @default.
• W3090433181 hasConceptScore W3090433181C122637931 @default.
• W3090433181 hasConceptScore W3090433181C142724271 @default.
• W3090433181 hasConceptScore W3090433181C145420912 @default.
• W3090433181 hasConceptScore W3090433181C159047783 @default.
• W3090433181 hasConceptScore W3090433181C187212893 @default.
• W3090433181 hasConceptScore W3090433181C2778385053 @default.
• W3090433181 hasConceptScore W3090433181C2779134260 @default.
• W3090433181 hasConceptScore W3090433181C3006700255 @default.
• W3090433181 hasConceptScore W3090433181C3007834351 @default.
• W3090433181 hasConceptScore W3090433181C3008058167 @default.
• W3090433181 hasConceptScore W3090433181C33923547 @default.
• W3090433181 hasConceptScore W3090433181C524204448 @default.
• W3090433181 hasConceptScore W3090433181C71924100 @default.
• W3090433181 hasConceptScore W3090433181C89623803 @default.
• W3090433181 hasIssue "4" @default.
• W3090433181 hasLocation W30904331811 @default.
• W3090433181 hasLocation W30904331812 @default.
• W3090433181 hasOpenAccess W3090433181 @default.
• W3090433181 hasPrimaryLocation W30904331811 @default.
• W3090433181 hasRelatedWork W3017171836 @default.
• W3090433181 hasRelatedWork W3025176011 @default.
• W3090433181 hasRelatedWork W3027835066 @default.
• W3090433181 hasRelatedWork W3032320397 @default.
• W3090433181 hasRelatedWork W3033635008 @default.
• W3090433181 hasRelatedWork W3152606407 @default.
• W3090433181 hasRelatedWork W4280491013 @default.
• W3090433181 hasRelatedWork W4308017287 @default.
• W3090433181 hasRelatedWork W3107152225 @default.
• W3090433181 hasRelatedWork W3183300108 @default.
• W3090433181 hasVolume "27" @default.
• W3090433181 isParatext "false" @default.
• W3090433181 isRetracted "false" @default.
• W3090433181 magId "3090433181" @default.
• W3090433181 workType "article" @default.